REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,870
0.00 (0.00%)
Feb 21, 2025, 9:00 AM KST

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 236.05 billion as of February 21, 2025. Its market cap has decreased by -18.85% in one year.

Market Cap
236.05B
Enterprise Value
382.10B
Revenue
149.84B
Ranking
n/a
PE Ratio
383.32
Stock Price
12,870.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 236.05B, an increase of 43.45%. That is a compound annual growth rate of 2.48%.

History

DateMarket Cap% Change
Feb 21, 2025236.05B0.23%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 81.78T
Celltrion 38.27T
Yuhan 9,148.44B
SK Biopharmaceuticals 9,053.01B
SK bioscience 3,756.75B
Hanmi Pharm. 3,417.32B
Hanmi Science 1,963.70B
Hanall Biopharma 1,934.60B
Market Cap Rankings